Martin Steegmaier PhD

Martin Steegmaier is Roche pRED’s (Roche Pharma Research & Early Development) Head of Discovery in Large Molecule Research at the Roche Innovation Center Munich in Germany. Martin earned his PhD in biochemistry from the University of Basel, Switzerland. Before joining the pharmaceutical industry he spent four years as a postdoctoral research fellow at Stanford University Medical School elucidating the biochemical mechanisms underlying neurotransmitter secretion and other vesicle trafficking events. In 2000, he joined Boehringer Ingelheim’s Oncology Drug Discovery Department and held positions with increasing responsibility. In 2006, he transitioned to Roche and held a number of positions before he was nominated Head of Discovery in Large Molecule Research in Roche pRED in March 2012.